Safety, tolerability and pharmacokinetics of WXFL10203614 in healthy Chinese subjects: A randomized, double-blind, placebo-controlled phase Ⅰ study

Objective: This study was conducted to investigate the safety, tolerability and pharmacokinetics (PK) of WXFL10203614 after single and multiple oral doses in healthy Chinese subjects. Methods: A single-center, randomized, double-blind, placebo-controlled phase Ⅰ study was performed on healthy Chines...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Kai, Ding, Ying, Que, Linling, Chu, Nannan, Shi, Yunfei, Qian, Zhenzhong, Qin, Wei, Chen, Yuanxin, Gu, Xianghong, Wang, Jiakun, Zhang, Zhiwei, Xu, Jianguo, He, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671933/
https://www.ncbi.nlm.nih.gov/pubmed/36408263
http://dx.doi.org/10.3389/fphar.2022.1057949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671933/
https://www.ncbi.nlm.nih.gov/pubmed/36408263
http://dx.doi.org/10.3389/fphar.2022.1057949

Ejemplares similares